statins are the most effective drugs available for lowering ldl and have revolutionized cardiovascular medicine. However, despite the widespread use of statins, many patients do not attain ldl goals and this is especially true in high and very high-risk patients in whom the ldl goals are even lower. Therefore, there is a demand for more potent statins.
rosuvastatin is the most potent statin for reducing ldl and was approved by us fda in august 2003. Rosuvastatin monotherapy may allow patients to attain ldl goals earlier and may help avoid combination therapy or potential adverse effects of high-dose statin therapy. Further, rosuvastatin has several advantages over all other statins- highest affinity for hmg-coa reductase, greater increase in hdl and fewer clinically significant drug interactions. In addition, rosuvastatin is the only statin to be approved by the us fda for slowing the progression of atherosclerosis. The safety profile of rosuvastatin is similar to other statins.
recently, the jupiter trial which showed significant reduction in cardiovascular events with rosuvastatin in healthy people with normal ldl and high c-reactive protein has added a new perspective in primary prevention therapy for statins. These results have the potential to revise guidelines and can have a huge impact on clinical practice.
rosulip is currently available in two strengths: rosulip 5 (5 mg rosuvastatin) and rosulip 10 (10 mg rosuvastatin). The dosage range of rosulip is 5-40 mg once daily at any time of the day and independent of food.
Cipla Limited 5yr
Ms. Namrata Jadhav (Manager)
Mumbai, Maharashtra, India
Send E-mail Enquiry
Updated: 19 Jun, 2013Pharmaceutical Tablets
Offering Pharmaceutical Tablets. Our range of pharmaceutical tablets iswidely appreciated for its accurate composition, and caters to the needsof pharmaceutical... more...
Magbro Healthcare Private Limited
Location: Ludhiana (India)
Updated: 19 Jun, 2013Belalive Tablet
Belalive tablet We are widely well reckoned as one of the salient livercare tablets manufacturer and exporter from India. Our herbal livertablets help in... more...
Location: Vadodara (India)
Drotaverin with Mefanamic Acid
Updated: 19 Jun, 2013Drotaverin with Mefanamic Acid
Composition Each tablet of gulspas contains: Drotaverine HCl . . . 80 mgMefenamic Acid . . . 250 mg Therapeutic indications & Usage gulspasis indicated for... more...
Popular Searches in Pharmaceutical Tablets• Pharmaceutical Pellets
Buyers Tool KitSend Buy Requirement
Suppliers Tool KitPost Products - FREE
Mobile Channel: Connect with us: